MIST vs MLEC

Milestone Pharmaceuticals Inc. vs Moolec Science SA — Valuation Comparison 2026

MIST

Biotechnology
Milestone Pharmaceuticals Inc.
Quality
3.6
out of 10
Value Trap
30
LOW
Price
$1.44
Last close
Models
7/13
Active
VS

MLEC

Biotechnology
Moolec Science SA
Quality
1.7
out of 10
Value Trap
Price
$7.20
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType MIST Fair ValueMIST Upside MLEC Fair ValueMLEC Upside
Bayesian DCF Intrinsic $0.50 -65.3% $1.91 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.23 -83.7% $0.35 -95.2%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for MIST vs MLEC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MIST vs MLEC — Which Stock Is More Undervalued?

MIST scores higher with a 3.6/10 quality rating vs MLEC's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Milestone Pharmaceuticals Inc. (MIST) and Moolec Science SA (MLEC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MIST currently trades at $1.44 with a QOC of 3.6/10, while MLEC trades at $7.20 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).